These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 9876055)

  • 21. A dose-finding study of azithromycin in the treatment of acne vulgaris.
    Basta-Juzbasić A; Lipozencić J; Oremović L; Kotrulja L; Gruber F; Brajac I; Marasović D; Andjelinović D; Herceg-Harjacek L; Cvitković L
    Acta Dermatovenerol Croat; 2007; 15(3):141-7. PubMed ID: 17868539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-ranging efficacy of new once-daily extended-release minocycline for acne vulgaris.
    Stewart DM; Torok HM; Weiss JS; Plott RT;
    Cutis; 2006 Oct; 78(4 Suppl):11-20. PubMed ID: 17436825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of oral azithromycin with oral doxycycline in the treatment of acne vulgaris.
    Ullah G; Noor SM; Bhatti Z; Ahmad M; Bangash AR
    J Ayub Med Coll Abbottabad; 2014; 26(1):64-7. PubMed ID: 25358221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial.
    Ozolins M; Eady EA; Avery AJ; Cunliffe WJ; Po AL; O'Neill C; Simpson NB; Walters CE; Carnegie E; Lewis JB; Dada J; Haynes M; Williams K; Williams HC
    Lancet; 2004 Dec 18-31; 364(9452):2188-95. PubMed ID: 15610805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic Comparison of Once-Daily Topical Minocycline Foam 4% vs Oral Minocycline for Moderate-to-Severe Acne.
    Jones TM; Ellman H; deVries T
    J Drugs Dermatol; 2017 Oct; 16(10):1022-1028. PubMed ID: 29036256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperthyroidism and lupus-like syndrome in an adolescent treated with minocycline for acne vulgaris.
    Benjamin RW; Calikoglu AS
    Pediatr Dermatol; 2007; 24(3):246-9. PubMed ID: 17542873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: A phase 3 study.
    Raoof TJ; Hooper D; Moore A; Zaiac M; Sullivan T; Kircik L; Lain E; Jankicevic J; Stuart I
    J Am Acad Dermatol; 2020 Apr; 82(4):832-837. PubMed ID: 31163231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective, randomized, open-label trial comparing the safety, efficacy, and tolerability of an acne treatment regimen with and without a probiotic supplement and minocycline in subjects with mild to moderate acne.
    Jung GW; Tse JE; Guiha I; Rao J
    J Cutan Med Surg; 2013; 17(2):114-22. PubMed ID: 23582165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE; Eady EA; Popescu C; Newton J; Li Wan Po A
    Cochrane Database Syst Rev; 2000; (2):CD002086. PubMed ID: 10796856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind comparison of topical clindamycin and oral minocycline in the treatment of acne vulgaris.
    Sheehan-Dare RA; Papworth-Smith J; Cunliffe WJ
    Acta Derm Venereol; 1990; 70(6):534-7. PubMed ID: 1981436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of minocycline for acne.
    Gottlieb A
    Lancet; 1997 Feb; 349(9049):374. PubMed ID: 9033461
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of minocycline and azithromycin for the treatment of mild scrub typhus in northern China.
    Zhao M; Wang T; Yuan X; Du W; Lin M; Shen Y
    Int J Antimicrob Agents; 2016 Sep; 48(3):317-20. PubMed ID: 27449540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of oral antibiotics on acne vulgaris and their effects on quality of life: a multicenter randomized controlled trial using minocycline, roxithromycin and faropenem.
    Hayashi N; Kawashima M
    J Dermatol; 2011 Feb; 38(2):111-9. PubMed ID: 21269305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adverse effects of minocycline in the treatment of acne vulgaris].
    Van Wayjen RG; Van den Ende A
    Ned Tijdschr Geneeskd; 1997 Oct; 141(40):1934-5. PubMed ID: 9550742
    [No Abstract]   [Full Text] [Related]  

  • 35. Benefit-risk assessment of acne therapies.
    Seukeran DC; Eady EA; Cunliffe WJ
    Lancet; 1997 Apr; 349(9060):1251-2. PubMed ID: 9130967
    [No Abstract]   [Full Text] [Related]  

  • 36. Minocycline treatment of tetracycline-resistant and tetracycline-responsive acne vulgaris.
    Rossman RE
    Cutis; 1981 Feb; 27(2):196-7, 201, 207. PubMed ID: 6452986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of acne vulgaris. A comparison of doxycycline versus minocycline].
    Laux B
    Hautarzt; 1989 Sep; 40(9):577-81. PubMed ID: 2530191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minocycline Topical Foam: A New Drug for the Treatment of Acne.
    Onge ES; Mobley WC
    Ann Pharmacother; 2021 Jan; 55(1):105-110. PubMed ID: 32618475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymecycline in the treatment of acne: an efficacious, safe and cost-effective alternative to minocycline.
    Bossuyt L; Bosschaert J; Richert B; Cromphaut P; Mitchell T; Al Abadie M; Henry I; Bewley A; Poyner T; Mann N; Czernielewski J
    Eur J Dermatol; 2003; 13(2):130-5. PubMed ID: 12695127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Chu A; Goulden V; Ambroziak M
    Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.